In patients with COPD, low levels of ST6GAL1 and α-2-6 sialylation are associated with poor prognosis, and this may relate to the regulatory effect of IL-6 expression/secretion by ST6GAL1 (57). This evidence concerns the gene ST6GAL1 and chronic obstructive pulmonary disease.